Glymphatic System Dysfunction Linked to Memory Issues in Epilepsy
This study looked at how the glymphatic system, which helps clear waste from the brain, functions in different types of temporal lobe epilepsy (TLE).
This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds arenโt enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
This study looked at how the glymphatic system, which helps clear waste from the brain, functions in different types of temporal lobe epilepsy (TLE).
This study looked at children with epilepsy and movement disorders, known as EPIMDs, to better understand their genetic causes and how these conditions present.
A study was conducted to examine how well a new inhalation device called Staccatoยฎ alprazolam works in adolescents aged 12 to 17 with epilepsy.
A study was conducted to understand how seizure frequency changes over time in people with treatment-resistant focal epilepsy (FTRE).
Researchers studied the effects of Ivermectin (IVM) on patients with drug-resistant epilepsy, which means their seizures are hard to control even with multiple medications.
Researchers studied how deep brain stimulation (DBS) and responsive neurostimulation (RNS) can help people with drug-resistant epilepsy (DRE), which is epilepsy that doesnโt respond to medications.
Researchers studied a case involving an 8-year-old boy with autism spectrum disorder (ASD) who experienced daily seizures.
This study focused on children with self-limited epilepsy with centrotemporal spikes (SeLECTs), a common type of epilepsy in kids.
Researchers studied the effectiveness of trigeminal nerve stimulation (TNS) as a treatment for people with drug-resistant epilepsy (DRE), which means their seizures do not respond to standard medications.